» Articles » PMID: 35057637

A Framework to Advance Biomarker Development in the Diagnosis, Outcome Prediction, and Treatment of Traumatic Brain Injury

Overview
Journal J Neurotrauma
Publisher Mary Ann Liebert
Date 2022 Jan 21
PMID 35057637
Authors
Affiliations
Soon will be listed here.
Abstract

Multi-modal biomarkers (e.g., imaging, blood-based, physiological) of unique traumatic brain injury (TBI) endophenotypes are necessary to guide the development of personalized and targeted therapies for TBI. Optimal biomarkers will be specific, sensitive, rapidly and easily accessed, minimally invasive, cost effective, and bidirectionally translatable for clinical and research use. For both uses, understanding how TBI biomarkers change over time is critical to reliably identify appropriate time windows for an intervention as the injury evolves. Biomarkers that enable researchers and clinicians to identify cellular injury and monitor clinical improvement, inflection, arrest, or deterioration in a patient's clinical trajectory are needed for precision healthcare. Prognostic biomarkers that reliably predict outcomes and recovery windows to assess neurodegenerative change and guide decisions for return to play or duty are also important. TBI biomarkers that fill these needs will transform clinical practice and could reduce the patient's risk for long-term symptoms and lasting deficits. This article summarizes biomarkers currently under investigation and outlines necessary steps to achieve short- and long-term goals, including how biomarkers can advance TBI treatment and improve care for patients with TBI.

Citing Articles

Repetitive Low-Level Blast Exposure Alters Circulating Myeloperoxidase, Matrix Metalloproteinases, and Neurovascular Endothelial Molecules in Experienced Military Breachers.

Rhind S, Shiu M, Tenn C, Nakashima A, Jetly R, Sajja V Int J Mol Sci. 2025; 26(5).

PMID: 40076437 PMC: 11898641. DOI: 10.3390/ijms26051808.


A Review of Advances in Multimodal Treatment Strategies for Chronic Disorders of Consciousness Following Severe Traumatic Brain Injury.

Liu S, Li X, Jiang S, Liu D, Wang J Int J Gen Med. 2025; 18:771-786.

PMID: 39967766 PMC: 11834669. DOI: 10.2147/IJGM.S502086.


Metabolomic in severe traumatic brain injury: exploring primary, secondary injuries, diagnosis, and severity.

Banoei M, Hutchison J, Panenka W, Wong A, Wishart D, Winston B Crit Care. 2025; 29(1):26.

PMID: 39815318 PMC: 11737060. DOI: 10.1186/s13054-025-05258-1.


Circulating Brain-Reactive Autoantibody Profiles in Military Breachers Exposed to Repetitive Occupational Blast.

Rhind S, Shiu M, Vartanian O, Tenn C, Nakashima A, Jetly R Int J Mol Sci. 2025; 25(24.

PMID: 39769446 PMC: 11728191. DOI: 10.3390/ijms252413683.


Synergistic label-free fluorescence imaging and miRNA studies reveal dynamic human neuron-glial metabolic interactions following injury.

Zhang Y, Savvidou M, Liaudanskaya V, Singh P, Fu Y, Nasreen A Sci Adv. 2024; 10(50):eadp1980.

PMID: 39661671 PMC: 11633737. DOI: 10.1126/sciadv.adp1980.


References
1.
Van Horn J, Bhattrai A, Irimia A . Multimodal Imaging of Neurometabolic Pathology due to Traumatic Brain Injury. Trends Neurosci. 2016; 40(1):39-59. PMC: 6492940. DOI: 10.1016/j.tins.2016.10.007. View

2.
Vespa P, Bergsneider M, Hattori N, Wu H, Huang S, Martin N . Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab. 2005; 25(6):763-74. PMC: 4347944. DOI: 10.1038/sj.jcbfm.9600073. View

3.
Bhattrai A, Irimia A, Van Horn J . Neuroimaging of traumatic brain injury in military personnel: An overview. J Clin Neurosci. 2019; 70:1-10. PMC: 6861663. DOI: 10.1016/j.jocn.2019.07.001. View

4.
Lindsey H, Wilde E, Caeyenberghs K, Dennis E . Longitudinal Neuroimaging in Pediatric Traumatic Brain Injury: Current State and Consideration of Factors That Influence Recovery. Front Neurol. 2020; 10:1296. PMC: 6927298. DOI: 10.3389/fneur.2019.01296. View

5.
Liu W, Wang B, Wolfowitz R, Yeh P, Nathan D, Graner J . Perfusion deficits in patients with mild traumatic brain injury characterized by dynamic susceptibility contrast MRI. NMR Biomed. 2013; 26(6):651-63. DOI: 10.1002/nbm.2910. View